A prospective study of pre-diagnostic circulating tryptophan and kynurenine, and the kynurenine/tryptophan ratio and risk of glioma.
暂无分享,去创建一个
M. Stampfer | K. Egan | Molin Wang | P. Ueland | Ø. Midttun | A. McCann | S. Smith-Warner | C. Samanic | D. Cote | Y. Yue
[1] T. Thamboo,et al. Tryptophan–kynurenine ratio as a biomarker of bladder cancer , 2020, BJU international.
[2] F. Mattivi,et al. Tryptophan Metabolic Pathways Are Altered in Obesity and Are Associated With Systemic Inflammation , 2020, Frontiers in Immunology.
[3] Yuanting Zheng,et al. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway , 2020, Signal Transduction and Targeted Therapy.
[4] V. Bours,et al. Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy , 2019, Journal of Translational Medicine.
[5] J. Gostner,et al. Tryptophan Metabolism and Related Pathways in Psychoneuroimmunology: The Impact of Nutrition and Lifestyle , 2019, Neuropsychobiology.
[6] G. Guillemin,et al. The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal , 2019, International journal of tryptophan research : IJTR.
[7] A. Badawy. Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects , 2017, International journal of tryptophan research : IJTR.
[8] C. James,et al. The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 Vaccine. , 2016, Immunotherapy.
[9] T. Rajkumar,et al. Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients. , 2016, Clinical biochemistry.
[10] A. Rademaker,et al. The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy , 2015, Journal of Clinical Neuroscience.
[11] G. Prendergast,et al. Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers , 2015, PloS one.
[12] A. Engin,et al. Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer. , 2015, World journal of gastroenterology.
[13] B. Brew,et al. Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology , 2014, PloS one.
[14] J. Barnholtz-Sloan,et al. The epidemiology of glioma in adults: a "state of the science" review. , 2014, Neuro-oncology.
[15] S. Vollset,et al. Interferon-γ–induced inflammatory markers and the risk of cancer: The Hordaland Health Study , 2014, Cancer.
[16] F. Clavel-Chapelon,et al. Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk. , 2014, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] W. Wick,et al. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. , 2012, Cancer research.
[18] M. Weller,et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.
[19] G. Oxenkrug. Metabolic syndrome, age‐associated neuroendocrine disorders, and dysregulation of tryptophan—kynurenine metabolism , 2010, Annals of the New York Academy of Sciences.
[20] K. Chida,et al. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer. , 2010, Lung cancer.
[21] P. Ueland,et al. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.
[22] S. Chanock,et al. ABO blood group and the risk of pancreatic cancer. , 2009, Journal of the National Cancer Institute.
[23] D. Fuchs,et al. Monitoring tryptophan metabolism in chronic immune activation. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[24] G. Colditz,et al. The Nurses' Health Study: lifestyle and health among women , 2005, Nature Reviews Cancer.
[25] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[26] F. Pattou,et al. CALL FOR PAPERS Integrative and Translational Physiology: Inflammation and Immunity in Organ System Physiology Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone , 2012 .